Fundraising Fox

Caribou Biosciences

4 known investors

cariboubio.com ↗

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform. The company licenses foundational CRISPR-Cas9 intellectual property and advances drug candidates for patients with devastating diseases.

BiotechMedical Devices

Founders & leadership

JD
Jennifer DoudnaCo-founder
RH
Rachel HaurwitzPresident and Chief Executive Officer, Co-founder
MJ
Martin JinekCo-founder

Investors · 4

Aliment CapitalLos Angeles
Avego BioScience CapitalAlpharetta
F-Prime Capital PartnersBoston
Mission BiocapitalSan Francisco · $500K – $500K

In the news